Immunoassay Analyzers Market Research Report- Forecast till 2027

Immunoassay Analyzers Market Research Report By Instruments (Immunofluorescence, Chemiluminescence, ELISA, Radioimmunoassay), Application (Infectious Diseases, Autoimmune Diseases, AIDS), End Users (Hospitals)- Forecast till 2027

ID: MRFR/MED/0694-HCR | August 2022 | Region: Global | 80 Pages         

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Immunoassay Analyzer Market, by Instrument

6.1 Introduction

6.2 Immunofluorescence

Market Estimates & Forecast, 2020-2027

6.3 Chemiluminescence

Market Estimates & Forecast, 2020-2027

6.4 ELISA

Market Estimates & Forecast, 2020-2027

6.5 Multiplexed Assay System

Market Estimates & Forecast, 2020-2027

6.6 Radioimmunoassay

Market Estimates & Forecast, 2020-2027

6.7 Others

Chapter 7. Global Immunoassay Analyzer Market, by Application

7.1 Introduction

7.2 Infectious Diseases

Market Estimates & Forecast, 2020-2027

7.3 Autoimmune Diseases

Market Estimates & Forecast, 2020-2027

7.4 AIDS

Market Estimates & Forecast, 2020-2027

7.5 Endocrinology

Market Estimates & Forecast, 2020-2027

7.6 Drug Monitoring

Market Estimates & Forecast, 2020-2027

7.7 Cardiology

Market Estimates & Forecast, 2020-2027

7.8 Oncology

Market Estimates & Forecast, 2020-2027

7.9 Allergy Testing

Market Estimates & Forecast, 2020-2027

7.10 Others

Chapter 8 Global Immunoassay Analyzer Market, by End User

8.1 Introduction

8.2 Hospitals

Market Estimates & Forecast, 2020-2027

8.3 Diagnostic Laboratories

Market Estimates & Forecast, 2020-2027

8.4 Research Institutes

Market Estimates & Forecast, 2020-2027

8.5 Others

Chapter 9. Global Immunoassay Analyzer Market, by Region

9.1 Introduction

9.2 America

9.2.1 North America

9.2.1.1 US

9.2.1.1 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic of Korea

9.4.6 Rest of Asia Pacific

9.5 The Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Kuwait

9.5.5 Qatar

9.5.6 Rest of the Middle East & Africa

Chapter 10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

Chapter 11 Company Profiles

11.1 F. Hoffmann-La Roche Ltd

11.1.1 Company Overview

11.1.2 Instrument Overview

11.1.3 Financials

11.1.4 SWOT Analysis

11.2 Siemens Ltd.

11.2.1 Company Overview

11.2.2 Instrument Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Abbott

11.3.1 Company Overview

11.3.2 Instrument Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Beckman Coulter, Inc.

11.4.1 Company Overview

11.4.2 Instrument/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Biokit S.A

11.5.1 Company Overview

11.5.2 Instrument Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.6 Immunodiagnostic Systems

11.6.1 Company Overview

11.6.2 Instrument Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.7 Merck KGaA

11.7.1 Overview

11.7.2 Instrument Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Others

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Medical Devices Industry

Chapter 13 Appendix



LIST OF TABLES

Table 1 Immunoassay Analyzer Industry Synopsis, 2020-2027

Table 2 Global Immunoassay Analyzer Market Estimates and Forecast, 2020-2027, (USD Million)

Table 3 Global Immunoassay Analyzer Market by Region, 2020-2027, (USD Million)

Table 4 Global Immunoassay Analyzer Market by Instruments, 2020-2027, (USD Million)

Table 5 Global Immunoassay Analyzer Market by Application, 2020-2027, (USD Million)

Table 6 Global Immunoassay Analyzer Market by End Users, 2020-2027, (USD Million)

Table 7 North America Immunoassay Analyzer Market by Instruments, 2020-2027, (USD Million)

Table 8 North America Immunoassay Analyzer Market by Application, 2020-2027, (USD Million)

Table 9 North America Immunoassay Analyzer Market by End Users, 2020-2027, (USD Million)

Table 10 US Market by Instruments, 2020-2027, (USD Million)

Table 11 US Immunoassay Analyzer Market by Application, 2020-2027, (USD Million)

Table 12 US Immunoassay Analyzer Market by End Users, 2020-2027, (USD Million)

Table 13 Canada Market by Instruments, 2020-2027, (USD Million)

Table 14 Canada Immunoassay Analyzer Market by Application, 2020-2027, (USD Million)

Table 15 Canada Immunoassay Analyzer Market by End Users, 2020-2027, (USD Million)

Table 16 South America Market by Instruments, 2020-2027, (USD Million)

Table 17 South America Immunoassay Analyzer Market by Application, 2020-2027, (USD Million)

Table 18 South America Immunoassay Analyzer Market by End Users, 2020-2027, (USD Million)

Table 19 Europe Market by Instruments, 2020-2027, (USD Million)

Table 20 Europe Immunoassay Analyzer Market by Application, 2020-2027, (USD Million)

Table 21 Europe Immunoassay Analyzer Market by End Users, 2020-2027, (USD Million)

Table 22 Western Europe Market by Instruments, 2020-2027, (USD Million)

Table 23 Western Europe Immunoassay Analyzer Market by Application, 2020-2027, (USD Million)

Table 24 Western Europe Immunoassay Analyzer Market by End Users, 2020-2027, (USD Million)

Table 25 Eastern Europe Market by Instruments, 2020-2027, (USD Million)

Table 26 Eastern Europe Immunoassay Analyzer Market by Application, 2020-2027, (USD Million)

Table 27 Eastern Europe Immunoassay Analyzer Market by End Users, 2020-2027, (USD Million)

Table 28 Asia Pacific Market by Instruments, 2020-2027, (USD Million)

Table 29 Asia Pacific Immunoassay Analyzer Market by Application, 2020-2027, (USD Million)

Table 30 Asia Pacific Immunoassay Analyzer Market by End Users, 2020-2027, (USD Million)

Table 31 Middle East & Africa Market by Instruments, 2020-2027, (USD Million)

Table 32 Middle East & Africa Immunoassay Analyzer Market by Application, 2020-2027, (USD Million)

Table 33 Middle East & Africa Immunoassay Analyzer Market by End Users, 2020-2027, (USD Million)



LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Immunoassay Analyzer Market

Figure 3 Segmentation Market Dynamics for Global Immunoassay Analyzer Market

Figure 4 Global Immunoassay Analyzer market Share, by Instrument 2020

Figure 5 Global Immunoassay Analyzer market Share, by Application 2020

Figure 6 Global Immunoassay Analyzer Market Share, by End Users, 2020

Figure 7 Global Immunoassay Analyzer Market Share, by Region, 2020

Figure 8 North America Immunoassay Analyzer Market Share, by Country, 2020

Figure 9 Europe Immunoassay Analyzer Market Share, by Country, 2020

Figure 10 Asia Pacific Immunoassay Analyzer Market Share, by Country, 2020

Figure 11 Middle East & Africa Immunoassay Analyzer Market Share, by Country, 2020

Figure 12 Global Immunoassay Analyzer Market: Company Share Analysis, 2020 (%)

Figure 13 F. Hoffmann-La Roche Ltd.: Key Financials

Figure 14 F. Hoffmann-La Roche Ltd.: Segmental Revenue

Figure 15 F. Hoffmann-La Roche Ltd.: Geographical Revenue

Figure 16 Siemens Ltd.: Key Financials

Figure 17 Siemens Ltd.: Segmental Revenue

Figure 18 Siemens Ltd.: Geographical Revenue

Figure 19 Abbott: Key Financials

Figure 20 Abbott: Segmental Revenue

Figure 21 Abbott: Geographical Revenue

Figure 22 Beckman Coulter, Inc.: Key Financials

Figure 23 Beckman Coulter, Inc.: Segmental Revenue

Figure 24 Beckman Coulter, Inc.: Geographical Revenue

Figure 25 Biokit S.A: Key Financials

Figure 26 Biokit S.A: Segmental Revenue

Figure 27 Biokit S.A: Geographical Revenue

Figure 28 Immunodiagnostic Systems: Key Financials

Figure 29 Immunodiagnostic Systems: Segmental Revenue

Figure 30 Immunodiagnostic Systems: Geographical Revenue

Figure 31 Merck KGaA: Key Financials

Figure 32 Merck KGaA: Segmental Revenue

Figure 33 Merck KGaA: Geographical Revenue

Immunoassay Analyzers Market

Immunoassay Analyzers Market is projected to be worth USD 28.19 Billion by 2028, registering a CAGR of 15.6% during the forecast period (2021 - 2028).

Segmentation

By Instruments Immunofluorescence Chemiluminescence Elisa Radioimmunoassay
By Application Infectious Diseases Autoimmune Diseases Aids
By End-User Hospitals

Key Players

  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Siemens Ltd. (Germany)
  • Abbott (US)
  • Beckman Coulter Inc. (US)
  • Ortho Clinical Diagnostics (US)
  • bioMérieux Private Limited (France)
  • Biokit S.A (Spain)
  • The Binding Site Group Ltd. (UK)
  • Immunodiagnostic Systems (UK)
  • Merck KGaA (US)
  • Olympus Corporation (Japan)
  • Nova Century Scientific Inc. (US)
  • Thermo Fisher Scientific (US)
  • DiaSorin S.p.A. (Italy)
  • Randox Laboratories Ltd. (UK).

Drivers

  • Increasing prevalence of different infectious immunological or metabolic diseases
  • Increasing demand of advanced diagnostic devices and recent trends of automation and integration
Speak to Analyst Request a Free Sample

Immunoassay Analyzers Market Scenario


Immunoassay is a test that measures the concentration of analytes in blood samples, this is done by an instrument known as immunoassay analyzer. This instrument measures the presence or concentration of proteins in analyte samples; using antigen-antibody binding properties. Increasing demand for the new and better drugs has led to increase the number of testing procedures. These assays are used to monitor and measure different types of diseases. The immunoassay analyzer market is majorly driven by an increasing prevalence of different infectious, immunological or metabolic diseases, increasing demand of advanced diagnostic devices and recent trends of automation and integration which together have led to the introduction of innovative products in immunoassay analyzer market. According to the Center of Disease Control and Prevention, over 17.8 million people suffers from infectious diseases each year. Beside this, rising number of patient suffering from cardiovascular diseases and diabetes has stimulated the demand for the different drugs and tests ultimately led to the growth of the immunoassay analyzer market. Furthermore, increasing geriatric population, changing lifestyle, growing habit of smoking and drinking along with increasing spending on healthcare have also fuelled the growth of immunoassay analyzer market. However, test and assays performed are strictly monitor and thus, strict regulatory requirement and high cost of the instruments may hinder this market’s growth.


The immunoassay analyzers market is growing at a healthy CAGR of 15.6% during the forecast period of 2017-2023. 


Intended Audience



  • Immunoassay Analyzers Manufacturer

  • Immunoassay Analyzers Supplier

  • Research and Development (R&D) Companies

  • Independent Research Laboratories

  • Market Research and Consulting Service Providers

  • Medical Research Laboratories

  • Academic Medical Institutes and Universities


Figure 1- Global immunoassay analyzers market, by application Immunoassay Analyzers Market


     Source- Annual reports, press release, white paper, company presentation 


Segmentation


The immunoassay analyzer immunoassay analyzer market is segmented on the basis of instruments, applications, and end users.


On the basis of instruments, the immunoassay analyzer market is classified into immunofluorescence, chemiluminescence, ELISA, enzyme linked fluorescent system, multiplexed assay system, radioimmunoassay and others.


On the basis of application, the immunoassay analyzer market is segmented into infectious diseases, autoimmune diseases, AIDS, endocrinology, drug monitoring, cardiology, oncology, allergy testing and others.


On the basis of end users, the immunoassay analyzer market is categorized into hospitals, diagnostic laboratories, research institutes, and others. 


Regional Analysis


America dominates the immunoassay analyzer market owing to large patient population and strong government support. Increasing diabetic population has also contributed in the growth of the immunoassay analyzer market market.  According to the WHO, in 2016, 9.6% of total America population were suffering from diabetes. In addition to this, changing lifestyle and increasing healthcare expenditure have boosted the growth of the market in America. Government and many companies are conducting many seminar in order to create awareness among the people which is created a room for the market growth.


Europe commands the second largest immunoassay analyzer market, which is followed by Asia Pacific. Presence of huge patient pool, and increasing government support will drive the immunoassay analyzer market in Europe. Asia Pacific is the fastest growing region for the market due to the presence of a rapidly developing economies, and increasing need for the better treatment. China and India are the major contributor for the immunoassay analyzer market.


On the other hand, the Middle East & Africa has the least share in the immunoassay analyzer market due to presence of poor economy especially in Africa region. Middle East holds the major share in the Middle East & Africa immunoassay analyzer market owing to well-developed healthcare sector and huge healthcare expenditure. 


Key Players


Some of the major key player in the immunoassay analyzer market are F. Hoffmann-La Roche Ltd.  (Switzerland), Siemens Ltd. (Germany), Abbott (US), Beckman Coulter, Inc. (US), Ortho Clinical Diagnostics (US), bioMérieux Private Limited (France), Biokit S.A (Spain), The Binding Site Group Ltd. (UK), Immunodiagnostic Systems (UK), Merck KGaA (US), Olympus Corporation (Japan), Nova Century Scientific, Inc. (US), Thermo Fisher Scientific (US), DiaSorin S.p.A. (Italy) and Randox Laboratories Ltd. (UK). 


Market Assessment


Immunoassay Analyzers Market-


Source- World Health Organization (WHO), White Paper, Company Presentation, Annual Reports


 



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   15.6% (2017-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Instruments, Applications, End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Ltd. (Germany), Abbott (US), Beckman Coulter, Inc. (US), Ortho Clinical Diagnostics (US), bioMérieux Private Limited (France), Biokit S.A (Spain), The Binding Site Group Ltd. (UK), Immunodiagnostic Systems (UK), Merck KGaA (US), Olympus Corporation (Japan), Nova Century Scientific, Inc. (US), Thermo Fisher Scientific (US), DiaSorin S.p.A. (Italy) and Randox Laboratories Ltd. (UK).
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Increasing prevalence of different infectious, immunological or metabolic diseases
  • Increasing demand of advanced diagnostic devices and recent trends of automation and integration


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Immunoassay analyzers market is expected to expand at 15.6% CAGR from 2017 to 2023.

    Rising demand of advanced diagnostic devices and increasing prevalence of chronic diseases are major drivers of the global immunoassay analyzers market.

    High costs of instruments and strict regulations pertaining to the approval of instruments can impede the global immunoassay analyzers market growth.

    The Americas can dominate the global immunoassay analyzers market due to the large number of diabetics.

    DiaSorin S.p., Siemens Ltd., Randox Laboratories Ltd., The Binding Site Group Ltd., F. Hoffmann-La Roche Ltd., Biokit S.A, Beckman Coulter, Inc., Olympus Corporation, Ortho Clinical Diagnostics, bioMérieux Private Limited, Abbott, Thermo Fisher Scientific, Nova Century Scientific, Inc., Merck KGaA, and Immunodiagnostic Systems are prominent players of the global immunoassay analyzers market.